Reticular
Y Combinator–backed company focused on scaling genomic AI for embryo selection and IVF risk reporting, offering at-home partner screening and reanalysis of existing PGT-A embryo data.
About Reticular
Reticular is scaling polygenic prediction for embryo selection, helping IVF couples plan their families today while building a platform to unlock cures for complex heritable diseases long-term.
John competed Biology Olympiads before spending 4 years at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.
Products
Reanalyzes existing PGT-A embryo data across all embryos and all cycles for a flat fee, screening 500+ pregnancy-loss genes and reporting lifelong health risk across 24+ conditi...
At-home saliva screening kit that screens 750+ reproductive genes tied to infertility and recurrent pregnancy loss.
Security and compliance
As reported by Reticular. Ask for audit reports before you buy.
- encryption_at_rest
- encryption_in_transit
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Reticular